Former US President Joe Biden, 82, has begun an intensive new phase in his battle with an aggressive, metastatic form of prostate cancer, undergoing radiation therapy in addition to existing hormone treatments. This development marks a significant point in his health journey, bringing renewed focus on advanced cancer care and the importance of early detection.
The health of former US President Joe Biden continues to be a subject of national interest as he undergoes radiation therapy for an aggressive form of prostate cancer. The 82-year-old commenced radiation and hormone treatment as part of his ongoing medical care, with the radiation phase expected to last approximately five weeks, according to reports from BBC and NBC News.
The Initial Diagnosis: An Aggressive and Metastatic Form
Biden’s medical team publicly revealed his diagnosis in May, detailing an aggressive form of prostate cancer that had unfortunately spread to his bones. The severity of his condition was underscored by a Gleason score of 9 (Grade Group 5), which indicates a high-grade, fast-growing cancer with a greater likelihood of spreading. This assessment was highlighted by experts like Dr. Benjamin Davies, a professor of urologic oncology at the University of Pittsburgh Medical Center. Despite its aggressive nature, the cancer was identified as “hormone-sensitive,” a crucial factor enabling effective management through targeted therapies, as confirmed by CNN.
The discovery of the cancer followed Biden experiencing urinary symptoms, which led to the identification of a prostate nodule. While the diagnosis of metastatic prostate cancer, particularly one that has spread to the bones, is generally considered incurable, the fact that it is hormone-sensitive offers significant hope for controlling its progression and improving the patient’s quality of life, according to medical professionals.
Understanding the Treatment Regimen
The current treatment plan for President Biden’s prostate cancer involves a multi-pronged approach:
- Radiation Therapy: This new phase of treatment, expected to span five weeks, aims to target cancer cells and help manage the disease’s progression, especially in areas where it has metastasized to the bones. While not a cure for metastatic cases, radiation can significantly alleviate symptoms and maintain control.
- Hormone Treatment (Androgen Deprivation Therapy – ADT): Biden had already begun a pill regimen as part of his hormone treatment. This therapy works by reducing testosterone levels, which are known to fuel prostate cancer growth. This is often a first-line treatment for hormone-sensitive metastatic prostate cancer.
- Bone-Targeting Treatments: Although not explicitly detailed for Biden, such treatments are commonly used in cases of bone metastasis to relieve pain and prevent further complications, alongside primary therapies.
Experts emphasize that treatment for advanced prostate cancer is highly personalized. Dr. Jamin Brahmbhatt, a urologist not involved in Biden’s care, highlighted that even with high-risk prostate cancer, patients “can live a pretty normal life and have a good quality of life, as long as the cancer is treated.” The advancements in hormonal and chemotherapy therapies in recent years have shown impressive results in extending patient longevity, as noted by Dr. Davies.
Biden’s Broader Health History and Advocacy
Beyond his prostate cancer diagnosis, Joe Biden has also faced other health challenges. In September, he underwent Mohs surgery to remove skin cancer lesions, a procedure typically used for fast-growing or recurring cancerous cells. This followed a similar procedure in 2023, during his presidency, when a lesion on his chest was removed and tested positive for basal cell carcinoma, the most common and usually curable type of skin cancer. These prior experiences underscore a history of dermatological vigilance.
Biden’s personal connection to cancer runs deep. In 2015, he lost his eldest son, Beau, to brain cancer. This profound loss fueled his long-standing advocacy for cancer research. In 2022, he and his wife, Jill Biden, relaunched the “cancer moonshot” initiative with an ambitious goal: to mobilize research efforts to prevent more than four million cancer deaths by 2047. This initiative highlights his commitment to fighting the disease on a broader scale, turning personal tragedy into public action.
The Public Conversation: Health, Screenings, and Political Implications
The news of Biden’s cancer diagnosis has naturally sparked public discourse, particularly concerning the health of prominent public figures. It also brought renewed attention to the importance of early detection and screening for prostate cancer, especially among older men. Prostate cancer is the second most common cancer affecting men, behind skin cancer, with age being the most common risk factor, according to the US Centers for Disease Control and Prevention (CDC).
Screening recommendations, which involve tests like the PSA (prostate-specific antigen) blood test and digital rectal exams, have evolved over the years, leading to varied patterns in early detection. Medical experts like Dr. Matthew Truong of Rochester Regional Health and Dr. Jean Joseph of the University of Rochester Medical Center emphasize the crucial role of early screening, particularly for older men, men of African American descent, and those with a family history of the disease. His diagnosis serves as a poignant reminder that this “silent process” can affect anyone, reinforcing the need for regular check-ups.
Politically, Biden’s health has been a recurring theme, particularly leading up to the 2024 election cycle. Concerns about his physical health and mental acuity contributed to his decision to step back from the presidential race after a challenging debate performance, eventually endorsing Vice President Kamala Harris. His current health status, while no longer directly impacting a sitting presidency, remains a significant part of his public legacy and highlights the human element behind political leadership.
Living with Metastatic Prostate Cancer: Hope and Management
While a diagnosis of metastatic prostate cancer can be daunting, medical advancements have transformed the outlook for many patients. The primary goal shifts from cure to effective management, focusing on slowing disease progression, controlling symptoms, and maintaining a high quality of life. For hormone-sensitive cases like Biden’s, doctors can achieve significant progress in controlling the disease, allowing many men to live for years with the diagnosis through ongoing treatment and monitoring.
The journey of individuals like George Savastano, who has lived with prostate cancer for over 20 years thanks to early detection and modern treatments, serves as an inspiring testament to the possibilities. The continuous evolution of therapies, from advanced radiation techniques to innovative hormone and bone-targeting drugs, offers a robust toolkit for managing even aggressive forms of the disease. Biden’s situation, therefore, exemplifies the ongoing advancements in oncology and the personalized approach required for complex cancer care.
